Search
17 studies match these filters. Showing 1–17 of 17 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07674654 | A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total | Recruiting | Phase 3 | 1,000target | 113 / 1 | 2026 | Aug 27, 2026 | |
| NCT07645924 | A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total · contact listed | Recruiting | Phase 3 | 1,800target | 113 / 1 | 2026 | Aug 20, 2026 | |
| NCT06582810 | Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · contact listed | Recruiting | 20target | 1 / 1 | 2025 | Jul 10, 2026 | ||
| NCT05125302 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 129 sites in total | Recruiting | Phase 3 | 1,059target | 129 / 2 | 2022 | Sep 14, 2026 | |
| NCT06527222 | A Study of Ranolazine in ALS The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed | Recruiting | Phase 2 | 72target | 6 / 1 | 2025 | Jun 8, 2026 | |
| NCT06847321 | Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is designed to target the P.… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed | Recruiting | Phase 2 | 300target | 38 / 1 | 2025 | Sep 15, 2026 | |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total | Recruiting | Phase 3 | 1,100target | 76 / 1 | 2024 | Jun 15, 2026 | |
| NCT01574053 | Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed | RecruitingNot verified since Feb 1, 2024 | 35,000target | 183 / 20 | 2012 | Feb 28, 2024 | ||
| NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed | Recruiting | Phase 3 | 400target | 66 / 12 | 2026 | Sep 17, 2026 | |
| NCT02523014 | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the g… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 783 sites in total | Recruiting | Phase 2 | 124target | 783 / 1 | 2015 | Sep 2, 2026 | |
| NCT06990867 | Optimizing Reperfusion to Improve Outcomes and Neurologic Function The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 83 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 740target | 83 / 18 | 2025 | Mar 13, 2026 | |
| NCT05065216 | Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 86 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 728target | 86 / 10 | 2021 | Sep 14, 2026 | |
| NCT05561127 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 33 sites in total · contact listed | Recruiting | Phase 3 | 171target | 33 / 1 | 2023 | Jun 25, 2025 | |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 71target | 38 / 16 | 2022 | Jun 15, 2026 | |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 181target | 31 / 14 | 2026 | Jun 23, 2026 | |
| NCT07546929 | HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed | Recruiting | Phase 2 | 300target | 25 / 1 | 2023 | Apr 23, 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed | Recruiting | 75,000target | 279 / 6 | 2015 | Aug 25, 2026 |